Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2

Status

Completed 17Recruiting 10Active not recruiting 9Unknown 8Terminated 5Withdrawn 3Not yet recruiting 3Enrolling by invitation 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 6Genitourinary 5Gastrointestinal 4Breast 4Tumor-Agnostic 1Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 4Prostate Cancer With Intermediate Risk 1Neoplasms 1

Interventions

Docetaxel 69pembrolizumab 48Prednisone 43Nivolumab 40enzalutamide 38Gemcitabine 37Sunitinib 36Cyclophosphamide 29Radiotherapy 26Magnetic Resonance Spectroscopy 26Leuprolide 25Abiraterone Acetate 25Sorafenib 23Everolimus 23Cisplatin 23bicalutamide 19atezolizumab 18Carboplatin 18Bevacizumab 18avelumab 17Radiosurgery 17Goserelin 17Interleukin-2 16abiraterone 15fludarabine 14Doxorubicin 14olaparib 13durvalumab 13cabozantinib 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Brachytherapy × Genitourinary × Clear all
NCT05224869 2025-02-26

Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer

Icahn School of Medicine at Mount Sinai

Phase NA Terminated
10 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00499174 2023-08-23

Observation or Radical Treatment in Patients With Prostate Cancer

Canadian Cancer Trials Group

Phase NA Terminated
180 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT01098331 2021-12-27

Implant Radiation Therapy or Surgery in Treating Patients With Prostate Cancer

University of Southampton

Phase NA Terminated
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT01374087 2019-09-18

ANABRAQ

Ipsen

Phase 2 Terminated
32 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT01039038 2011-11-28

CURIEBOOST

Centre Francois Baclesse

Phase 2 Terminated
50 enrolled
Genitourinary

Prostate Cancer With Intermediate Risk

Data powered by HemOnc (CC BY 4.0) Colophon âš¡